New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified.

The respiratory virus HMPV uses its fusion (F) protein – which interacts with cellular receptors called integrins – to bind to and enter target cells.

A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies.

The protein Syk is essential for clearing away neuron “corpses” in the developing peripheral nervous system.

A transcription factor called LIP is capable of causing one cell to consume another.

Dysfunction or loss of an “antioxidant” enzyme may lead to higher risk for esophageal cancer in patients with gastric reflux disease.

Deep brain stimulation used to treat Parkinson’s disease may impair some aspects of language processing, a recent study suggests.